Analyst Actions
Uber Picks Up a Fundamental Passenger: Should Investors Share the Ride?
The stock has doubled in the past 12 months.
Legend Biotech's Story Is Still Playing Out
Let's check the charts after this biotech reports earnings and snags a new 'buy' recommendation.
Chevron: Drilling Down on the Charts
Here's where aggressive traders could probe.
DraftKings: We're 'Doubling Down' on Our Bullish Recommendation
Here are our latest price targets.
CSX Looks on Track for an Upside Breakout
It appears traders of the railroad's stock have become aggressive buyers rather than aggressive sellers.
Range Resources Has Made an Upside Breakout
Let's see what traders could do now.
Apollo Global Is Poised for a Rally
Here's my first price target and where traders could risk to.
Gilead Sciences Touches a Key Moving Average, So Is It Time to Buy?
It looks as though the answer could be yes as the shares of the biopharmaceutical company have built a nice base.
Alcoa: Here's When Traders Should Prepare to Be Buyers
Let's delve into the charts and indicators.
CyberArk Trolls in Choppy Chart Waters as It Gains an Analyst's Thumbs Up
The stock of the identity software firm has found support near its current price in the past, but there is no guarantee that will happen again.